Unlocking the secrets of Amish longevity
Longevity Technology - 15-Sep-2023How genetic insights could redefine ageing and extend healthy living for all
Join the club for FREE to access the whole archive and other member benefits.
Biotechnology company
Zoe Biosciences is a biotechnology company committed to redefining healthspan by developing therapeutic solutions for ageing and age-related diseases. At the heart of its research is the study of a unique genetic mutation found in an Amish community in Indiana. This mutation, affecting the gene for PAI-1 (Plasminogen Activator Inhibitor-1), has been linked to extended lifespan and improved healthspan, offering protection against various ageing-related diseases. Zoe's approach is inspired by this "Amish Longevity Platform," leveraging these insights to develop drugs targeting PAI-1 and related pathways to delay ageing and promote healthier lives.
The company's work is led by CEO Scott Gies, whose diverse background spans neuroscience, epigenetics, and longevity-focused ventures, and Chief Scientific Officer Dr. Douglas Vaughan, a leading expert on the molecular biology of ageing and PAI-1. Together, the team is advancing therapies that integrate cutting-edge science and the genetic advantages observed in this Amish population
Visit website: https://zoebiosciences.com/
Details last updated 13-Dec-2024
How genetic insights could redefine ageing and extend healthy living for all